Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Wet Macular Degeneration

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Wet Macular Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brouzas, D; Koutsandrea, C; Koutsilieris, M; Ladas, D; Moschos, MM; Nitoda, E; Philippou, A1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Wet Macular Degeneration

ArticleYear
Correlation of platelet activating factor and age-related macular degeneration.
    Expert opinion on therapeutic targets, 2014, Volume: 18, Issue:9

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Middle Aged; Platelet Activating Factor; Retina; Severity of Illness Index; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration

2014